Global Blood Therapeutics, Inc.·4

Mar 9, 5:30 PM ET

Sham Hing 4

4 · Global Blood Therapeutics, Inc. · Filed Mar 9, 2018

Insider Transaction Report

Form 4
Period: 2018-03-07
Sham Hing
See Remarks
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-03-0710,71410,715 total
    Exercise: $0.49Exp: 2024-09-09Common Stock (10,714 underlying)
  • Exercise/Conversion

    Common Stock

    2018-03-07$0.49/sh+10,714$5,25098,215 total
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on July 28, 2015, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION